Posts

Morepen Q2FY27 Results: Standalone PAT Up 442%, CDMO Scales

Image
SumanSpeaks Independent Capital Markets & Geopolitical Intelligence PHARMACEUTICALS | Q2FY27 EARNINGS Morepen Laboratories Q2FY27: Standalone PAT Up 442%, CDMO Turns Commercial A standalone profit of ₹77.87 crore against ₹14.38 crore a year ago, consolidated profit of ₹88.89 crore, and CDMO revenue up roughly 334% to about ₹253 crore. Add exports of ₹397 crore for the quarter and 20 million glucose meters in the field, and Morepen no longer fits the label of a sleepy API maker. Morepen Laboratories (₹99.15) (NSE: MOREPENLAB | BSE: 500288 | ISIN: INE083A01026) did something rare in the September quarter. It earned a standalone profit of ₹77.87 crore, against ₹14.38 crore a year ago, a rise of 442%. On a consolidated basis, net profit more than doubled to ₹88.89 crore, up 117.48%, on revenue from operations of ₹746.50 crore, up 81.4%. A 442% jump sounds like a typo until you look at the base. The percentage is the headline, but the rupee figure is the part worth framing:...

Indowind Energy After Q2FY27: A Windy-Season Profit, and Solar Could Change the Equation

Image
SumanSpeaks Independent Capital Markets & Geopolitical Intelligence Renewable Energy · Quarterly Results Indowind Energy After Q2FY27: A Windy-Season Profit, and Solar Could Change the Equation Consolidated net profit of ₹3.07 crore, revenue of ₹15.38 crore and an operating margin approaching 53%. With a 4 MW solar project approaching completion and a potential recovery in wind generation, Indowind is entering an interesting phase of its renewable-energy journey. Indowind Energy Ltd (₹8.66) has delivered a substantially stronger sequential performance in Q2FY27. Consolidated revenue from operations nearly doubled over the preceding quarter, while operating profitability remained impressive. The September quarter is traditionally important for wind-power generation. However, the more interesting development is taking shape beyond the existing wind portfolio. Indowind is working towards adding solar generation to its asset base, potentially creating a more div...

Did Dr. B. R. Ambedkar Misread the Vedas? Sri Aurobindo’s Very Different Interpretation and Why the Two Readings Matter

Image
SumanSpeaks Independent Capital Markets & Geopolitical Intelligence Weekend Reading Did Dr. B. R. Ambedkar Misread the Vedas? Sri Aurobindo’s Very Different Interpretation and Why the Two Readings Matter Aurobindo began serialising The Secret of the Veda in August 1914. Ambedkar wrote Riddles in Hinduism in 1954–55. One questioned the accepted interpretation of the ancient hymns; the other delivered a sweeping verdict substantially through translated selections. The question is whether that verdict survives a closer examination of the evidence. Have we truly understood the Vedas, or have we judged them through an interpretative framework that never seriously investigated what might lie beneath their ritual language? Hold that question in your mind through everything that follows. Dr. B. R. Ambedkar examined the Vedas and found little or nothing worth defending. Sri Aurobindo examined the same ancient tradition and discovered what he believed to be a profound l...

Popular posts from this blog